Fig. 2From: Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trialsTotal VTE and all-cause mortality during treatment period by subgroup (risk differences)Back to article page